Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine. 1984

B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel

Radioiodinated m-iodobenzylguanidine has been applied mainly for the diagnosis of pheochromocytoma and blastoma. In this paper we show that an ontogenetically related tumor, the neuroblastoma, is also scintigraphically visualized by its high uptake of I-131 MIBG. Because of the kinetic findings and the high uptake of more than 30% of the injected activity, it is likely that the neuroblastoma, by analogy with pheochromocytoma, is susceptible to specific radionuclide therapy.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007462 Iodobenzenes Any derivative of BENZENE that contains IODINE.
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000008 Abdominal Neoplasms New abnormal growth of tissue in the ABDOMEN. Abdominal Neoplasm,Neoplasm, Abdominal,Neoplasms, Abdominal
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents
D019797 3-Iodobenzylguanidine A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase. (3-Iodo-(131I)benzyl)guanidine,Iobenguane,MIBG,3-Iodobenzylguanidine, 123I Labeled,3-Iodobenzylguanidine, 125I Labeled,Iobenguane (131I),m-Iodobenzylguanidine,meta-Iodobenzylguanidine,123I Labeled 3-Iodobenzylguanidine,125I Labeled 3-Iodobenzylguanidine,3 Iodobenzylguanidine,3 Iodobenzylguanidine, 123I Labeled,3 Iodobenzylguanidine, 125I Labeled,m Iodobenzylguanidine,meta Iodobenzylguanidine

Related Publications

B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
November 1985, Kaku igaku. The Japanese journal of nuclear medicine,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
February 1991, Cancer,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
January 1991, Annales de medecine interne,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
January 1988, Progress in clinical and biological research,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
February 1984, Lancet (London, England),
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
January 1988, Klinische Padiatrie,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
December 1986, Minerva pediatrica,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
January 1987, Pediatric radiology,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
October 1990, Nederlands tijdschrift voor geneeskunde,
B Kimmig, and W E Brandeis, and M Eisenhut, and B Bubeck, and H J Hermann, and K zum Winkel
December 1985, Nuklearmedizin. Nuclear medicine,
Copied contents to your clipboard!